Oct 21, 2022 / 11:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to Jubilant Pharmova Limited Earnings Conference Call for the Quarter and Half Year Ended September 30, 2022. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Surajit Pal, Head, Investor Relations. Thank you. And over to you, Mr. Pal.
Surajit Pal;Head of Investor Relations -
Thank you. Good evening, everyone. Thank you for being with us on our Q2 and H1 FY '23 earnings conference call. I would like to remind you that some of the statements made on the call today could be forward-looking in nature, and a detailed disclaimer in this regard has been included in the press release that has been shared on our website.
On the call today, we have Mr. Shyam Bhartia, Chairman; Mr. Hari Bhartia, Co-Chairman and Managing Director; Mr. Arvind Chokhany, Group CFO; Mr. Pramod Yadav, CEO of Jubilant Pharma; Mr. Giuliano Perfetti, CEO of Jubilant Biosys; Mr. Syed Kazmi, CEO of Jubilant Therapeutics; and Mr. Arun Sharma, CFO of Jubilant Pharmova
Q2 2023 Jubilant Pharmova Ltd Earnings Call Transcript
Oct 21, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers